Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

OptiCept Technologies

1.94 SEK

-0.41 %

Less than 1K followers

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for OptiCept Technologies

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue3.95.417.75.31.219.80.927.2
EBITDA-9.9-14.9-42.5-12.4-16.00.1-43.7-72.1
EBIT-12.5-17.5-56.1-15.0-18.6-2.5-48.2-84.3
EBIT-%-321.4 %-325.3 %-317.4 %-284.3 %-1,563.9 %-12.7 %-5,186.8 %-309.6 %
Profit before taxes-13.2-17.8-55.9-16.0-19.1-4.1-51.5-90.7
Net income-13.2-17.6-55.7-16.0-19.1-4.1-51.3-90.5
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.